TCG Crossover

About TCG Crossover

TCG Crossover is a science-driven investment firm dedicated to advancing disruptive medicines.

Specialties

Disruptive Medicines Science-Driven Investments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Fund III T: - FT: Fund III	A: 1300000000 MR: - FA: 1.3 billion FAN: 1300000000	D: 2025-10-06 FD: 2025-10-06	5 investors
2	RT: Fund Raise T: - FT: Fund Raise	A: 1000000000 MR: - FA: $1B FAN: 1000000000	D: 2024-01-04 FD: 2024-01-04	1 investors

Fund III Latest

2025-10-06

$1.3B

5 investors (Pro only)

Fund Raise 2024-01-04

$1.0B

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chen Yu

Managing Partner

C

Cariad Chester

Managing Partner

G

Giuliano Marostica

Partner

D

Dandan Dong

Venture Partner

G

George Feng

Associate (Bioengineer)

B

Bill Zhang

Analyst

View 27 more team members with Pro

Unlock Full Team Directory

Recent News

TCG Crossover Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised